drugset / Trial / NCT05106153

A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem

NCT05106153

Phase 1 Completed 127 enrolled Janssen Research & Development, LLC
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate the abuse potential of seltorexant compared to placebo and two active comparators (zolpidem and suvorexant) in non-dependent, recreational sedative users.

Timeline

Start
2021-12-17
Primary completion
2023-05-12
Completion
2023-05-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Seltorexant Small molecule Oral
Subject Suvorexant Small molecule Oral
Subject Zolpidem Small molecule Oral

Indications